Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OneMedNet CorpONMD · Entity 9052 | Director | August 14, 2024 | November 27, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OneMedNet Corp
Report date August 14, 2024 · Filed November 27, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 381,525 |
Ending reported balance
After 2025-11-26 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-08-14 · Grant · Acquired 17,260 · Balance 254,382 F1: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Row 2 · 2025-01-01 · Grant · Acquired 82,143 · Balance 336,525 F2: Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued service with the issuer through each vesting date (the "Time Vesting Schedule"), and (ii) 50% of the RSUs vest on the Time Vesting Schedule if the issuer's revenue exceeds a specific threshold determined by the Board of Directors. Row 3 · 2025-11-26 · Grant · Acquired 45,000 · Balance 381,525 F3: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024.
F2: Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued service with the issuer through each vesting date (the "Time Vesting Schedule"), and (ii) 50% of the RSUs vest on the Time Vesting Schedule if the issuer's revenue exceeds a specific threshold determined by the Board of Directors.
F3: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025273 · ownership.xml · nonDerivative · entry 3 Zeinfeld Andrew B · CIK 0001361934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,525 F3 · shares: Represents RSUs granted as director compensation under the 2022 Plan for board service in fiscal year 2025. The RSUs vest on December 31, 2025, subject to the reporting person's continued service with the issuer through the vesting date. Read SEC document |
| January 01, 2025 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | GrantCommon Stock | 82,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025273 · ownership.xml · nonDerivative · entry 2 Zeinfeld Andrew B · CIK 0001361934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,525 F2 · shares: Represents RSUs granted as director compensation under the 2022 Plan for service on the Commercial Committee. The RSUs vest as follows: (i) 50% of the RSU vest quarterly on the last day of each quarter for the applicable calendar year, subject to the reporting person's continued service with the issuer through each vesting date (the "Time Vesting Schedule"), and (ii) 50% of the RSUs vest on the Time Vesting Schedule if the issuer's revenue exceeds a specific threshold determined by the Board of Directors. Read SEC document |
| August 14, 2024 Filed Nov 27, 2025 02:54 UTC | OneMedNet Corp ONMD · Entity 9052 | GrantCommon Stock | 17,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025273 · ownership.xml · nonDerivative · entry 1 Zeinfeld Andrew B · CIK 0001361934 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,382 F1 · shares: Represents restricted stock units ("RSUs") granted as director compensation under the OneMedNet Corporation 2022 Equity Incentive Plan (the "2022 Plan") for board service in fiscal year 2024. Each RSU represents the contingent right to receive one share of the issuer's common stock. The RSUs vested on December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.